NIH pumps $3M into Feinstein autism study
The National Institutes of Health will fund a two-year Feinstein Institute for Medical Research study exploring risk factors behind autism spectrum disorders in newborns. A $3 million NIH grant has…
Feinstein Institute
Feinstein eyes bioelectronic BP breakthrough
A new study by the head of the Feinstein Institute for Medical Research may open the door to bioelectronic treatments for hypertension and high blood pressure. In a study published…
Feinstein researchers nab major NIH awards
Two cutting-edge Feinstein Institute for Medical Research projects have been selected for an elite National Institutes of Health funding program. Kevin Tracey, the institute’s president and CEO, and Ping Wang,…
Study is big news for Vagus pioneer Tracey
By GREGORY ZELLER // Medical science has taken an enormous step toward “using electronics to replace drugs.” Kevin Tracey’s words sound downright science-fictional. And no, researchers cannot wave a medical…
Feinstein’s Tracey to head bioelectronics summit
Feinstein Institute chief and global bioelectronics pioneer Kevin Tracey will headline a September New York Academy of Science conference on bioelectronic medicine. Tracey, Feinstein’s president and CEO and the brains…
TheraSource snags $3M SBIR grant
By GREGORY ZELLER // A Feinstein Institute-born biotech will tackle radiation poisoning thanks to a grant from the National Institute of Allergy and Infectious Diseases. TheraSource, a Manhasset-based 2004 startup…
Feinstein launching Neural Tourniquet as newco
By GREGORY ZELLER // Meet Sanguistat, the corporate face of the latest technology spinning out of Northwell Health’s Feinstein Institute for Medical Research. For now, Sanguistat is not an Inc….
The Debrief: Chris Czura has the pulse of the future
Healthcare and data-driven tech are the cornerstones of the innovation economy, making the Feinstein Institute for Medical Research, the R&D wing of the North Shore-LIJ Health System, the public face…
Battelle superstar to head bioelectronics center
Chad Bouton, an expert in decoding the brain waves that have allowed paralyzed patients to move or operate a wheel chair by thought alone, has been named managing director of…
Answering our ‘pent-up need’ for new industry
By JOHN L. KOMINICKI // A proposed $300 million center on bioelectronic research would get a $50 million jolt if Albany follows recommendations made this week by a group of business…
A giant step on the road to precision medicine
By GREGORY ZELLER // This is your brain. This is your brain on antipsychotic medications. Any questions? Investigators at the Feinstein Institute for Medical Research, the R&D wing of the…
With VNS, additional strides in controlling epilepsy
By GREGORY ZELLER // Dr. Ashesh Mehta, head of North Shore-LIJ’s epilepsy care center, performed two surgeries on July 24, one fairly routine, one a bit less so. For now,…
Debrief: John Boockvar, Feinstein Institute
John Boockvar has a lot on his mind, most of it regarding your mind. The co-director of the Feinstein Institute’s Brain Tumor Biotech Center is also an investigator in Feinstein’s…
Feinstein, Battelle partner on ‘Neural Tourniquet’
North Shore-LIJ’s Feinstein Institute is partnering with Ohio health giant Battelle on a so-called Neural Tourniquet that will reshape the way doctors staunch blood loss, from the battlefield to the…
Feinstein partnering with Australian pharma
The Feinstein Institute for Medical Research has inked a partnership deal with Novogen, an Australian pharmaceuticals giant and parent company of San Diego-based MEI Pharma, which produces a growing list…